At Close: 4:00 PM
Nuvalent Stock Price Graph
Nuvalent Stock Price Today
Nuvalent, Inc. (NUVL) stock rallied over 6.43% intraday to trade at $66.2 a share on NASDAQ. The stock opened with a loss of -17.42% at $53.98 and touched an intraday high of $53.98, rising 1.27% against the last close of $65.37. The Nuvalent, Inc. in stock market went to a low of $50.50 during the session.
Nuvalent Stock Snapshot
Number of Shares
Cash Flow per Share
Free Float in %
Nuvalent Stock Price History Chart
Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferring resistance to approved and investigational ROS1 inhibitors, which is under Phase I development; and NVL-655, a brain-penetrant ALK-selective inhibitor, to address the clinical challenges of emergent treatment resistance, central nervous system-related adverse events, and brain metastases that might limit the use of first-, second-, and third-generation ALK inhibitors that is under Phase I/II clinical trial. The company was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
Frequently Asked Questions
What is the current Nuvalent, Inc. (NUVL) stock price?
Nuvalent, Inc. (NASDAQ: NUVL) stock price is $66.20 in the last trading session. During the trading session, NUVL stock reached the peak price of $53.98 while $50.50 was the lowest point it dropped to. The percentage change in NUVL stock occurred in the recent session was 6.43% while the dollar amount for the price change in NUVL stock was $4.00.
NUVL's industry and sector of operation?
The NASDAQ listed NUVL is part of Biotechnology industry that operates in the broader Healthcare sector. Nuvalent, Inc. , a clinical stage biopharmaceutical company, develops therapies for patients with cancer.
Who are the executives of NUVL?
Mr. Matthew Metivier
Vice President of HR
Dr. James R. Porter Ph.D.
Chief Executive Officer, Pres & Director
Ms. Alex Balcom CPA, M.B.A.
Chief Financial Officer & Treasurer
Mr. John Soglia Ph.D.
Senior Vice President of Translational Devel.
How NUVL did perform over past 52-week?
NUVL's closing price is 4.46% higher than its 52-week low of $23.095 where as its distance from 52-week high of $65.5 is -0.04%.
How many employees does NUVL have?
Number of NUVL employees currently stands at N/A. NUVL operates from One Broadway, Cambridge, MA 02142, US.
Link for NUVL official website?
Official Website of NUVL is: https://www.nuvalent.com
How do I contact NUVL?
How many shares of NUVL are traded daily?
NUVL stock volume for the day was 585287.00 shares. The average number of NUVL shares traded daily for last 3 months was 715.39 Thousands.
What is the market cap of NUVL currently?
The market value of NUVL currently stands at $4.15 Billion with its latest stock price at $66.20 and N/A of its shares outstanding.